Buphenyl

Active Ingredient(s): Sodium Phenylbutyrate
FDA Approved: * April 30, 1996
Pharm Company: * MEDICIS
Category: Hyperammonemia

Sodium phenylbutyrate is a salt of an aromatic fatty acid, 4-phenylbutyrate (4-PBA) or 4-phenylbutyric acid.[2] The compound is used to treat urea cycle disorders, because its metabolites offer an alternative pathway to the urea cycle to allow excretion of excess nitrogen.[3][4] It is an orphan drug, marketed by Ucyclyd Pharma under the trade name Buphenyl, by Swedish Orphan International (Sweden) as Ammonaps, aby Fyrlklövern Scandinavia as... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Buphenyl .94 g/g Oral Powder
NDC: 62592-188
Labeler:
Ucyclyd Pharma Inc.
Buphenyl 500 mg Oral Tablet
NDC: 62592-496
Labeler:
Ucyclyd Pharma Inc.
Buphenyl 500 mg Oral Tablet
NDC: 75987-060
Labeler:
Horizon Pharma, Inc.
Buphenyl .94 g/g Oral Powder
NDC: 75987-070
Labeler:
Horizon Pharma, Inc.
Buphenyl .94 g/g Oral Powder
NDC: 76325-188
Labeler:
Hyperion Therapeutics, Inc.
Buphenyl 500 mg/1 Oral Tablet
NDC: 76325-496
Labeler:
Hyperion Therapeutics, Inc.

Related Brands

Drugs with the same active ingredients